207 related articles for article (PubMed ID: 22189833)
21. Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate.
Allen MR; Iwata K; Phipps R; Burr DB
Bone; 2006 Oct; 39(4):872-9. PubMed ID: 16765660
[TBL] [Abstract][Full Text] [Related]
22. Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis.
Chavassieux PM; Arlot ME; Reda C; Wei L; Yates AJ; Meunier PJ
J Clin Invest; 1997 Sep; 100(6):1475-80. PubMed ID: 9294113
[TBL] [Abstract][Full Text] [Related]
23. Dose-response relationships for alendronate treatment in osteoporotic elderly women. Alendronate Elderly Osteoporosis Study Centers.
Bone HG; Downs RW; Tucci JR; Harris ST; Weinstein RS; Licata AA; McClung MR; Kimmel DB; Gertz BJ; Hale E; Polvino WJ
J Clin Endocrinol Metab; 1997 Jan; 82(1):265-74. PubMed ID: 8989272
[TBL] [Abstract][Full Text] [Related]
24. Effects of long-term alendronate treatment on postmenopausal osteoporosis bone material properties.
Hassler N; Gamsjaeger S; Hofstetter B; Brozek W; Klaushofer K; Paschalis EP
Osteoporos Int; 2015 Jan; 26(1):339-52. PubMed ID: 25315260
[TBL] [Abstract][Full Text] [Related]
25. Relating micromechanical properties and mineral densities in severely suppressed bone turnover patients, osteoporotic patients, and normal subjects.
Tjhia CK; Stover SM; Rao DS; Odvina CV; Fyhrie DP
Bone; 2012 Jul; 51(1):114-22. PubMed ID: 22561877
[TBL] [Abstract][Full Text] [Related]
26. Alendronate treatment of the brtl osteogenesis imperfecta mouse improves femoral geometry and load response before fracture but decreases predicted material properties and has detrimental effects on osteoblasts and bone formation.
Uveges TE; Kozloff KM; Ty JM; Ledgard F; Raggio CL; Gronowicz G; Goldstein SA; Marini JC
J Bone Miner Res; 2009 May; 24(5):849-59. PubMed ID: 19113917
[TBL] [Abstract][Full Text] [Related]
27. The effects of bone remodeling inhibition by alendronate on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis.
Ding M; Danielsen CC; Hvid I
Calcif Tissue Int; 2008 Jan; 82(1):77-86. PubMed ID: 18175032
[TBL] [Abstract][Full Text] [Related]
28. Duration-dependent effects of clinically relevant oral alendronate doses on cortical bone toughness in beagle dogs.
Burr DB; Liu Z; Allen MR
Bone; 2015 Feb; 71():58-62. PubMed ID: 25445446
[TBL] [Abstract][Full Text] [Related]
29. Comparison of effects of alfacalcidol and alendronate on mechanical properties and bone collagen cross-links of callus in the fracture repair rat model.
Saito M; Shiraishi A; Ito M; Sakai S; Hayakawa N; Mihara M; Marumo K
Bone; 2010 Apr; 46(4):1170-9. PubMed ID: 20026440
[TBL] [Abstract][Full Text] [Related]
30. Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: a histomorphometric analysis of transiliac biopsies.
Chavassieux PM; Arlot ME; Roux JP; Portero N; Daifotis A; Yates AJ; Hamdy NA; Malice MP; Freedholm D; Meunier PJ
J Bone Miner Res; 2000 Apr; 15(4):754-62. PubMed ID: 10780867
[TBL] [Abstract][Full Text] [Related]
31. Bone matrix quality in paired iliac bone biopsies from postmenopausal women treated for 12 months with strontium ranelate or alendronate.
Falgayrac G; Farlay D; Ponçon C; Béhal H; Gardegaront M; Ammann P; Boivin G; Cortet B
Bone; 2021 Dec; 153():116107. PubMed ID: 34260980
[TBL] [Abstract][Full Text] [Related]
32. The effect of alendronate on biomineralization at the bone/implant interface.
Karlsson J; Martinelli A; Fathali HM; Bielecki J; Andersson M
J Biomed Mater Res A; 2016 Mar; 104(3):620-629. PubMed ID: 26507381
[TBL] [Abstract][Full Text] [Related]
33. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
[TBL] [Abstract][Full Text] [Related]
34. Accretion of bone quantity and quality in the developing mouse skeleton.
Miller LM; Little W; Schirmer A; Sheik F; Busa B; Judex S
J Bone Miner Res; 2007 Jul; 22(7):1037-45. PubMed ID: 17402847
[TBL] [Abstract][Full Text] [Related]
35. Density and structural changes in the bone of growing rats after weekly alendronate administration with and without a methotrexate challenge.
Spadaro JA; Damron TA; Horton JA; Margulies BS; Murray GM; Clemente DA; Strauss JA
J Orthop Res; 2006 May; 24(5):936-44. PubMed ID: 16609966
[TBL] [Abstract][Full Text] [Related]
36. Effect of alendronate on periodontal disease in postmenopausal women: a randomized placebo-controlled trial.
Rocha ML; Malacara JM; Sánchez-Marin FJ; Vazquez de la Torre CJ; Fajardo ME
J Periodontol; 2004 Dec; 75(12):1579-85. PubMed ID: 15732857
[TBL] [Abstract][Full Text] [Related]
37. Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass.
Felsenberg D; Bock O; Börst H; Armbrecht G; Beller G; Degner C; Stephan-Oelkers M; Schacht E; Mazor Z; Hashimoto J; Roth HJ; Martus P; Runge M
J Musculoskelet Neuronal Interact; 2011 Mar; 11(1):34-45. PubMed ID: 21364273
[TBL] [Abstract][Full Text] [Related]
38. Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis.
Stepan JJ; Burr DB; Pavo I; Sipos A; Michalska D; Li J; Fahrleitner-Pammer A; Petto H; Westmore M; Michalsky D; Sato M; Dobnig H
Bone; 2007 Sep; 41(3):378-85. PubMed ID: 17597017
[TBL] [Abstract][Full Text] [Related]
39. Tissue mineralization is increased following 1-year treatment with high doses of bisphosphonates in dogs.
Burr DB; Miller L; Grynpas M; Li J; Boyde A; Mashiba T; Hirano T; Johnston CC
Bone; 2003 Dec; 33(6):960-9. PubMed ID: 14678856
[TBL] [Abstract][Full Text] [Related]
40. Mapping Bone Changes at the Proximal Femoral Cortex of Postmenopausal Women in Response to Alendronate and Teriparatide Alone, Combined or Sequentially.
Whitmarsh T; Treece GM; Gee AH; Poole KE
J Bone Miner Res; 2015 Jul; 30(7):1309-18. PubMed ID: 25639838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
